Funding

TestDynamics Secures $9 Million With Series A Backing for Medical Imaging AI Evaluation

Evan Mercer
Add Unite.AI to your preferred sources on Google
Conceptual radiology monitors connected to a unified medical imaging review panel
AI-generated illustration of medical imaging AI evaluation and a unified radiology workflow.
Key PointsSatori evaluates imaging algorithms on each hospital's own studies before purchase…
View more
  • Satori evaluates imaging algorithms on each hospital's own studies before purchase decisions.
  • TestDynamics argues evaluation must come from outside the model rather than from algorithm vendors.
  • Satori Edge de-identifies studies inside the hospital network and routes them only to enabled vendors.

TestDynamics has secured $9 million in funding, with a Series A led by Healthier Capital and strategic participation from Cedars-Sinai Technology Ventures. The Austin-based company will use the capital to expand Satori, a vendor-neutral platform that evaluates medical imaging AI algorithms and brings their findings into radiologists’ existing workflows.

The financing targets a problem that grows as hospitals adopt more AI: selecting an algorithm is only the beginning. Health systems also need to establish how it performs on their patients, connect it to clinical software, and determine whether it continues to deliver useful results after deployment.

TestDynamics says Satori is already in clinical use at several of the ten highest-ranked U.S. medical centers. It plans to expand its clinical validation team, deploy across more health systems, and extend its evaluation and orchestration capabilities into additional imaging subspecialties. The announcement does not name those medical centers or disclose a valuation.

An Evaluation Layer Above Competing Imaging Algorithms

Medical imaging AI is often specialized. One tool might flag suspected bleeding on a head CT, while another measures structures on an MRI or identifies possible fractures on an X-ray. Buying several tools can leave radiologists reconciling separate interfaces, findings, and vendor-specific performance claims.

Satori sits above those tools rather than competing as another narrow diagnostic algorithm. TestDynamics calls its approach Amalgamated Intelligence: evaluating outputs from multiple systems and organizing the results into a prioritized clinical view. The company says it benchmarks algorithms against both reference findings, often called ground truth, and competing products.

“Evaluation must come from outside the model,” said founder and CEO Lior Eshel in the announcement. His argument is that hospitals need an evaluator whose role is separate from the companies selling the algorithms.

The platform description adds a practical detail to that position: candidate tools are tested on the provider’s own de-identified imaging studies before clinicians and leadership choose them. Their results establish a local baseline for subsequent monitoring. A model’s performance elsewhere is useful evidence, but a local evaluation tests whether that evidence carries over to the hospital’s actual imaging workload.

How Satori Connects to a Hospital’s Imaging Systems

The integration component is Satori Edge, a service installed within the hospital network. According to TestDynamics’ technical overview for IT teams, it receives studies from a picture archiving and communication system, or PACS, and from DICOM routers. PACS stores and retrieves medical images; DICOM is the standard used to exchange those images and associated information.

Edge de-identifies and encrypts studies before they leave the network, routes them only to enabled AI vendors, and reconnects the returned results with the correct patient on site. TestDynamics says the service uses outbound connections and that its vendor agreements prohibit retaining patient data or using it for training.

This architecture gives the hospital one connection through which it can introduce or replace tools. It also consolidates contracting: TestDynamics holds agreements and business associate agreements with the underlying AI vendors. Those agreements address responsibilities for handling protected health information, while the technical connection handles movement of studies and results.

A Unified View, With Radiologists Approving Findings

The phrase “one result” can suggest that multiple AI answers are blended into a new diagnosis. The company’s Satori View documentation describes a more specific workflow: individual results appear as the originating algorithm produced them, organized into a consistent view at the point of reading.

Clinical sections can choose which findings appear and how they are ordered. Radiologists approve what goes into the imaging viewer or draft report. Priority flags from cleared triage tools can also reach worklists, while follow-up tracking helps keep incidental findings visible until they are addressed.

That distinction matters for accountability. A radiologist needs to understand which tool produced a finding and whether to accept it. Reducing interface clutter is useful; preserving the ability to examine and reject an output is equally consequential.

Monitoring Performance After Go-Live

Satori Governance extends evaluation into ongoing operations. TestDynamics says it tracks performance against each hospital’s baseline, monitors usage, compares AI findings with final reports, and collects radiologists’ agreements, overrides, and disagreements. Leadership can use that record to decide whether to keep, replace, or expand a tool.

Monitoring is intended to expose drift: a change in performance after the conditions surrounding a model change. Scanner upgrades, different imaging protocols, new patient populations, or updated model versions can all create reasons to examine whether an earlier evaluation still applies.

Agreement with a final report is a useful signal, but it is not automatically equivalent to an independently adjudicated ground truth. Reviewing disagreements and defining reliable reference cases remain important parts of clinical validation. The funding’s emphasis on expanding a validation team reflects the human work behind this infrastructure.

Funding the Infrastructure Around Clinical AI

The demand for external evaluation extends beyond imaging. A 2024 Nature Medicine comment on clinical validation argued for stronger evidence standards for authorized AI health tools. Unite.ai has also covered independent testing of healthcare AI, reflecting a wider push to assess systems against evidence outside their developers’ own claims.

Healthier Capital’s participation backs an infrastructure thesis: hospitals will need to change AI vendors without rebuilding their clinical systems around each replacement. Cedars-Sinai Technology Ventures adds a healthcare commercialization investor to the round; TestDynamics also identifies itself as a participant in the Cedars-Sinai Accelerator’s 2023 program.

For TestDynamics, the opportunity is to make evaluation, integration, and clinical oversight a continuing service rather than separate projects for every algorithm. The $9 million financing will help it expand that layer, with its value ultimately resting on whether hospitals gain clearer evidence about their tools and a more usable flow of findings for radiologists.

Evan Mercer is an AI-generated research agent at Unite.AI, covering AI startups, venture capital, and the funding dynamics shaping the next generation of technology companies. His reporting focuses on early-stage innovation, capital flows, and the strategic decisions founders and investors make as AI companies scale from concept to global impact.

With a strategic and analytical lens, Evan examines funding rounds, market positioning, and emerging trends across the AI startup ecosystem. He tracks how venture capital, corporate investment, and public markets intersect with breakthroughs in artificial intelligence, separating durable signals from short-term hype.

Articles authored by Evan Mercer are AI-generated and reviewed by Unite.AI’s editorial team to ensure accuracy, context, and responsible coverage of the global AI investment landscape